• Search
  • Advanced Search
Clin Mol Hepatol > Accepted Articles
Correspondence
Correspondence to editorial “Targeting CD36 to reinvigorate CD8+ T Cells in early-stage hepatocellular carcinoma”
Yifei Qin1,2,3, Peng Lin2,3, Huijie Bian2,3, Zhi-Nan Chen2,3, Jiao Wu2,3
1Institutes of Biomedicine and Department of Cell Biology, Jinan University, Guangzhou 510632, China
2Department of Cell Biology, National Translational Science Center for Molecular Medicine, Fourth Military Medical University, 710032, China
3State Key Laboratory of New Targets Discovery and Drug Development for Major Diseases, China
Correspondence :  Jiao Wu ,
Email: jiaowubio@hotmail.com
Received: April 11, 2025   Accepted: April 24, 2025
KeyWords: CD8+ T dysfunction, Lipid peroxidation, Iron accumulation, Ferroptosis, Hepatocellular carcinoma, CD36
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 1,204 View
  • 19 Download
Related articles

Correspondence: Response to Editorial on “Uncovering the MET-TRIB3-FOXO1 axis: A Novel Target in MET-driven Hepatocellular Carcinoma”

Correspondence: Response to Editorial on “Unveiling TRIB3: A New Mediator in MET-Driven Hepatocellular Carcinoma Progression”

Correspondence to editorial “Metabolic health in antiviral era of chronic hepatitis B”

Targeting CD36 to reinvigorate CD8+ T Cells in early-stage hepatocellular carcinoma

Correspondence: Response to the Letter Regarding "GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma"

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 2480
TOTAL : 2784142
Close layer